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In this edition of the Libyan Journal of Medicine, Zorgani 
and co-workers report on the value of clindamycin in 
treating infections in burn patients caused by 
staphylococci with special reference to methicillin-resistant 
Staphylococcus aureus (MRSA) [1]. They studied 110 
isolates of Staphylococcus aureus and determined that 
inducible resistance to clindamycin occurred in two-thirds 
of MRSAs, but was not seen with methicillin-sensitive S. 
aureus (MSSA). The ‘D-test’ (which is so called because of 
the shape of inhibition produced on the plate) was 
recommended for use in local microbiology laboratories to 
determine inducible resistance in staphylococci [2,3]. Most 
routine laboratories may find it easier to rely simply on the 
results of erythromycin testing. Clindamycin can be 
reported as being sensitive in staphylococci that are 
sensitive to erythromycin. MRSAs are typically resistant to 
erythromycin and so clindamycin is unlikely to be effective 
in the treatment of most MRSA infections. Alternative 
agents are available that have established efficacy in the 
treatment of MRSA infections. These include the 
glycopeptides (vancomycin & teicoplanin), linezolid, 
daptomycin, tetracyclines and tigecycline [4]. 
 
What is most interesting about this paper is that an 
alarming 59% of S. aureus isolates were MRSAs. Clearly 
this study was not meant to be a surveillance study, but it 
has highlighted the presence of significant nosocomial 
infections in Libya. If one assumes that these isolates are 
representative of the trends in the Tripoli Burn Centre 
then the presence of such a large proportion of S. aureus 
isolates as MRSA indicates that the unit (and probably 
many other specialist units all over the country) are in the 
grip of endemic problems with highly resistant nosocomial 
organisms. MRSA has probably been circulating in Libyan 
hospitals for at least 2 decades. On a visit to the 
microbiology laboratory at the 7th April Hospital in 
Benghazi in 1993 it came to my attention that many of the 
S. aureus isolates, when tested accurately, were in fact 
MRSAs. 
 
There is very little information in the international 
literature about nosocomial infections in Libya whereas 
they are a cause of considerable morbidity and mortality in 
the industrialised and developing countries. In the latter 
m o r e  t h a n  2 5 %  o f  a l l  h o s p ital admissions develop 
nosocomial infections and these rates can be 20 times 
higher than in developed countries [5,6]. 
 
There is a responsibility by public and private healthcare 
providers in Libya to microbiologically investigate patients 
with suspected nosocomial infections to ensure that 
appropriate antimicrobial treatment can be given. These 
investigations require well-equipped, properly manned and 
accredited microbiology laboratories. Such laboratories are 
now rare in Libya. In a dysfunctional healthcare 
environment it is easy to scale down or eliminate 
laboratory services because of the perceived expense 
while channelling limited funds only to clinical services. 
Poorly-run microbiology laboratories end up producing 
unreliable results which clinicians ignore. Lack of reliable 
microbiological laboratory services leads clinicians to the 
widespread use of empirical (blind) antimicrobial therapy 
with patients being offered a variety of antimicrobials until 
the curative one is found. Empiricism in the use of 
antimicrobials without proper microbiological 
investigations encourages the development of antibiotic-
resistant nosocomial pathogens. As these organisms are 
not being identified, clinicians are forced to use different 
types of antimicrobials many of which will have no 
beneficial effect on the patient but will increase the pool of 
nosocomial pathogens, thus further aggravating the 
situation. This abuse of antimicrobials only exacerbates 
the problem of nosocomial infections and frustrates 
clinicians in their attempts to cure infections. The 
availability of nearly all antimicrobials on an over-the 
counter basis in Libya further complicates the problem. 
Economising on microbiology laboratory services is a false 
economy because the spread of nosocomial organisms 
leads to infections that are more expensive to treat. Each 
case of Clostridium difficile diarrhoea costs the UK health 
service an average extra of about $6000 [6]. Diagnosing 
accurately the microbial cause of each nosocomial 
infection becomes ever more important when one 
considers the need to limit the spread of hospital 
pathogens from patient to patient .  I t  i s  ve r y  d i f f i c u l t  t o  
enforce infection prevention and control measures without 
laboratory support [7]. Outbreaks can continue indefinitely 
in hospitals and remain totally undetected. 
 
It should also be noted that more than 70% of all health 
care decisions in the UK relating to prevention, diagnosis, 
and treatment of disease involve a pathology 
investigation. Investing in medical laboratory services is no 
longer a luxury, but is essential if the healthcare 
requirements of the population are to be taken seriously. 
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